We found that U0126 treatment significantly inhibited cell proliferation, migration, and invasion in PCDH/TRAF3IP3-transfected glioma cells and that the activation of the ERK signaling pathway mediated by TRAF3IP3 overexpression could be rescued by U0126. Here, TRAF3IP3 is linked to central nervous system cancer.